Baihua Pharma (600721.SH) announced that its wholly-owned subsidiary Nanjing Baihua Xinsen Biomedical Technology Co., Ltd. ...
Baihua Pharma (600721.SH) announced that its wholly-owned subsidiary Nanjing Baihua Xinsen Biomedical Technology Co., Ltd. (referred to as "Baihua Xinsen") has jointly established the ChuanYu Gaozhu Xinqu Guangyi Xing (Chongqing) Private Equity Investment Fund Partnership Enterprise (Limited Partnership) with Sichuan Yaoyigou Technology Group Co., Ltd., Guangan Investment Group Co., Ltd., and Beijing Hailiang Gaoke Technology Co., Ltd. as limited partners, and Guang'an Xiaoping Hometown Development Fund Management Co., Ltd. and Beijing Anlong Entrepreneurship Investment Fund (Limited Partnership) as general partners. Baihua Xinsen used its own funds to make a paid-in contribution of 9.5 million yuan, accounting for 7.60% of the total paid-in capital of the target fund. The fund partnership agreement was signed on July 18, 2024.